Walnuts may help prevent Alzheimer's: study

Image
Press Trust of India New York
Last Updated : Oct 22 2014 | 3:35 PM IST
A walnut-enriched diet may help reduce the risk, delay the onset or slow the progression of Alzheimer's disease, a new study, led by an Indian-origin researcher, has found.
The study found significant improvement in learning skills, memory, reducing anxiety, and motor development in mice fed a walnut-enriched diet.
Researchers suggest that the high antioxidant content of walnuts (3.7 mmol/ounce) may have been a contributing factor in protecting the mouse brain from the degeneration typically seen in Alzheimer's disease.
Oxidative stress and inflammation are prominent features in this disease, researchers said.
"These findings are very promising and help lay the groundwork for future human studies on walnuts and Alzheimer's disease - a disease for which there is no known cure," said lead researcher Abha Chauhan, head of the Developmental Neuroscience Laboratory at the New York State Institute for Basic Research in Developmental Disabilities (IBR).
"Our study adds to the growing body of research that demonstrates the protective effects of walnuts on cognitive functioning," Chauhan said.
The research group examined the effects of dietary supplementation on mice with 6 per cent or 9 per cent walnuts, which are equivalent to 1 ounce and 1.5 ounces per day, respectively, of walnuts in humans.
This research stemmed from a previous cell culture study led by Chauhan that highlighted the protective effects of walnut extract against the oxidative damage caused by amyloid beta protein.
This protein is the major component of amyloid plaques that form in the brains of those with Alzheimer's disease.
Walnuts have other nutritional benefits as they contain numerous vitamins and minerals and are the only nut that contains a significant source of alpha-linolenic acid (ALA) (2.5 grammes per ounce), an omega-3 fatty acid with heart and brain-health benefits.
The researchers also suggest that ALA may have played a role in improving the behavioural symptoms seen in the study.
The study was published in the Journal of Alzheimer's Disease.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 22 2014 | 3:35 PM IST

Next Story